Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach

BACKGROUND: Minimally invasive diagnostic biomarkers for patients with pancreatic ductal adenocarcinoma (PDAC) and distal cholangiocarcinoma (dCCA) are warranted to facilitate accurate diagnosis. This study identified diagnostic plasma proteins based on proteomics of tumor secretome. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Large, Tessa Y.S., Meijer, Laura L., Paleckyte, Rosita, Boyd, Lenka N.C., Kok, Bart, Wurdinger, Thomas, Schelfhorst, Tim, Piersma, Sander R., Pham, Thang V., van Grieken, Nicole C.T., Zonderhuis, Barbara M., Daams, Freek, van Laarhoven, Hanneke W.M., Bijlsma, Maarten F., Jimenez, Connie R., Giovannetti, Elisa, Kazemier, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160420/
https://www.ncbi.nlm.nih.gov/pubmed/31943574
http://dx.doi.org/10.1634/theoncologist.2019-0680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160420/
https://www.ncbi.nlm.nih.gov/pubmed/31943574
http://dx.doi.org/10.1634/theoncologist.2019-0680

Ejemplares similares